[Hub]/) : Traits : Impedance of leg (right) :

chr14:103,161,201-104,892,153

Best TWAS P=9.88e-12 · Best GWAS P=5.42e-11 conditioned to 0.00235

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Adipose Subcutaneous MARK3 0.12 0.05 lasso 3 0.06 2.5e-05 5.9 5.9 4.2e-09 0.69 0.09 0.90 FALSE
2 GTEx Adipose Visceral Omentum KLC1 0.06 0.02 lasso 2 0.00 2.2e-01 6.1 -6.5 1.0e-10 -0.57 0.10 0.38 FALSE
3 GTEx Adrenal Gland KLC1 0.15 0.03 lasso 3 0.06 4.6e-03 -4.7 -6.0 1.6e-09 -0.52 0.11 0.34 FALSE
4 GTEx Artery Aorta KLC1 0.10 0.14 lasso 3 0.14 6.1e-08 6.0 -6.3 2.9e-10 -0.59 0.08 0.92 FALSE
5 GTEx Artery Tibial ZFYVE21 0.11 0.09 lasso 1 0.08 8.0e-07 5.9 -5.9 3.4e-09 -0.60 0.10 0.90 FALSE
6 GTEx Artery Tibial KLC1 0.11 0.08 lasso 3 0.08 1.1e-06 6.1 -5.9 2.8e-09 -0.61 0.09 0.90 FALSE
7 GTEx Artery Tibial TRMT61A 0.07 0.07 lasso 3 0.06 2.4e-05 5.8 6.5 9.4e-11 0.84 0.02 0.98 FALSE
8 GTEx Breast Mammary Tissue MARK3 0.12 0.11 lasso 2 0.08 3.9e-05 6.0 6.0 1.9e-09 0.69 0.07 0.89 FALSE
9 GTEx Breast Mammary Tissue KLC1 0.12 0.02 enet 26 0.07 2.9e-04 -4.7 -5.6 2.5e-08 -0.41 0.76 0.15 FALSE
10 GTEx Breast Mammary Tissue (Male) MARK3 0.08 0.00 enet 9 -0.01 7.2e-01 6.0 6.7 2.0e-11 0.66 0.03 0.37 FALSE
11 GTEx Cells Transformed fibroblasts ZFYVE21 0.10 0.03 lasso 4 0.11 1.1e-08 5.1 -5.4 5.5e-08 -0.56 0.23 0.60 FALSE
12 GTEx Cells Transformed fibroblasts KLC1 0.16 0.11 enet 17 0.10 3.1e-08 -4.2 -5.3 9.7e-08 -0.43 0.94 0.05 FALSE
13 GTEx Cells Transformed fibroblasts APOPT1 0.14 0.12 lasso 3 0.10 6.4e-08 5.9 6.3 3.2e-10 0.57 0.10 0.90 FALSE
14 GTEx Esophagus Mucosa KLC1 0.17 0.09 lasso 5 0.12 1.6e-08 -4.7 -5.4 6.7e-08 -0.42 0.92 0.06 FALSE
15 GTEx Esophagus Muscularis ZFYVE21 0.11 0.06 lasso 5 0.05 5.7e-04 5.7 -5.8 5.9e-09 -0.61 0.14 0.77 FALSE
16 GTEx Esophagus Muscularis KLC1 0.07 0.01 enet 10 0.02 2.6e-02 6.0 -6.1 1.2e-09 -0.58 0.07 0.66 FALSE
17 GTEx Lung MARK3 0.06 0.02 lasso 3 0.01 6.6e-02 6.0 6.5 6.6e-11 0.77 0.04 0.91 FALSE
18 GTEx Lung CKB 0.07 0.01 lasso 2 0.01 3.4e-02 6.1 6.5 7.7e-11 0.71 0.05 0.85 FALSE
19 GTEx Muscle Skeletal ZFYVE21 0.10 0.05 lasso 2 0.03 3.3e-04 5.9 -5.6 2.8e-08 -0.56 0.10 0.85 FALSE
20 GTEx Muscle Skeletal KLC1 0.11 0.07 lasso 7 0.08 3.3e-08 6.0 -5.7 9.0e-09 -0.55 0.09 0.91 FALSE
21 GTEx Muscle Skeletal APOPT1 0.14 0.21 enet 10 0.22 6.7e-21 5.7 -5.9 3.3e-09 -0.62 0.30 0.70 FALSE
22 GTEx Pituitary MARK3 0.21 0.27 enet 8 0.25 4.9e-07 6.0 6.3 3.1e-10 0.70 0.06 0.89 FALSE
23 GTEx Prostate MARK3 0.18 0.22 enet 11 0.20 8.0e-06 6.0 6.0 2.6e-09 0.69 0.08 0.85 FALSE
24 GTEx Skin Not Sun Exposed Suprapubic MARK3 0.16 0.10 lasso 3 0.10 6.7e-06 6.1 6.2 6.5e-10 0.67 0.06 0.94 FALSE
25 GTEx Skin Not Sun Exposed Suprapubic XRCC3 0.14 0.03 lasso 14 0.03 1.3e-02 -4.7 -5.2 2.5e-07 -0.37 0.61 0.24 FALSE
26 GTEx Skin Not Sun Exposed Suprapubic CKB 0.28 0.26 lasso 4 0.25 6.4e-14 6.5 6.6 4.6e-11 0.98 0.00 1.00 FALSE
27 GTEx Skin Sun Exposed Lower leg MARK3 0.10 0.09 enet 13 0.08 7.5e-07 5.9 5.9 3.5e-09 0.76 0.08 0.92 FALSE
28 GTEx Skin Sun Exposed Lower leg CKB 0.43 0.32 enet 16 0.34 5.9e-29 6.5 6.4 1.3e-10 0.96 0.00 1.00 FALSE
29 GTEx Stomach MARK3 0.10 0.09 lasso 2 0.04 4.5e-03 6.0 6.0 2.7e-09 0.68 0.08 0.76 FALSE
30 GTEx Stomach TRMT61A 0.12 0.11 lasso 5 0.08 1.2e-04 6.0 6.0 1.9e-09 0.69 0.07 0.88 FALSE
31 GTEx Testis ZFYVE21 0.11 0.14 lasso 2 0.11 1.4e-05 5.9 -5.9 2.9e-09 -0.60 0.09 0.85 FALSE
32 GTEx Thyroid MARK3 0.38 0.48 lasso 4 0.48 2.8e-41 6.0 6.0 2.1e-09 0.69 0.08 0.92 FALSE
33 NTR Blood BAG5 0.02 0.00 lasso 5 0.01 6.3e-03 5.7 -5.8 8.6e-09 -0.64 0.19 0.60 FALSE
34 YFS Blood KLC1 0.01 0.01 blup 389 0.01 1.0e-03 5.4 -6.8 9.9e-12 -0.61 0.11 0.70 TRUE
35 The Cancer Genome Atlas Breast Invasive Carcinoma C14orf153 0.05 0.02 lasso 4 0.02 8.0e-05 5.7 5.8 5.3e-09 0.64 0.01 0.98 FALSE
36 The Cancer Genome Atlas Breast Invasive Carcinoma CKB 0.06 0.03 lasso 3 0.03 2.5e-06 6.6 6.6 4.9e-11 0.98 0.00 1.00 FALSE
37 The Cancer Genome Atlas Colon Adenocarcinoma C14orf153 0.07 0.05 lasso 4 0.04 1.5e-03 5.7 5.6 1.9e-08 0.61 0.01 0.84 FALSE
38 The Cancer Genome Atlas Glioblastoma Multiforme C14orf153 0.14 0.01 blup 40 0.03 3.5e-02 5.7 5.9 2.9e-09 0.73 0.01 0.53 FALSE
39 The Cancer Genome Atlas Glioblastoma Multiforme MARK3 0.12 0.05 blup 64 0.07 3.3e-03 6.1 5.2 1.8e-07 0.58 0.02 0.27 FALSE
40 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma MARK3 0.07 0.03 blup 64 0.06 5.5e-07 6.5 5.9 2.7e-09 0.85 0.01 0.99 FALSE
41 The Cancer Genome Atlas Lung Adenocarcinoma C14orf153 0.06 0.02 blup 38 0.04 2.4e-05 5.7 5.7 1.3e-08 0.54 0.02 0.92 FALSE
42 The Cancer Genome Atlas Lung Squamous Cell Carcinoma CKB 0.03 0.00 blup 34 0.02 1.4e-03 -2.8 5.4 6.9e-08 0.69 0.01 0.81 FALSE
43 The Cancer Genome Atlas Lung Squamous Cell Carcinoma TRMT61A 0.02 0.00 blup 34 0.01 6.2e-02 -3.3 5.5 3.2e-08 0.62 0.02 0.39 FALSE
44 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma BAG5 0.08 0.09 lasso 2 0.08 3.7e-04 6.0 6.0 2.3e-09 0.69 0.00 0.96 FALSE
45 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma C14orf153 0.11 0.11 lasso 3 0.10 1.1e-04 5.7 5.6 2.1e-08 0.60 0.01 0.95 FALSE
46 The Cancer Genome Atlas Prostate Adenocarcinoma C14orf153 0.09 0.08 blup 38 0.09 6.2e-10 5.7 6.2 4.7e-10 0.64 0.01 0.99 FALSE
47 The Cancer Genome Atlas Prostate Adenocarcinoma MARK3 0.07 0.06 enet 7 0.08 1.0e-08 6.6 6.8 1.0e-11 0.95 0.00 1.00 FALSE
48 The Cancer Genome Atlas Prostate Adenocarcinoma TRMT61A 0.03 0.01 blup 32 0.01 1.4e-02 5.8 5.2 2.3e-07 0.50 0.01 0.19 FALSE
49 The Cancer Genome Atlas Rectum Adenocarcinoma BAG5 0.17 -0.01 blup 32 0.02 1.3e-01 -2.9 5.4 6.0e-08 0.62 0.01 0.46 FALSE
50 The Cancer Genome Atlas Testicular Germ Cell Tumors C14orf153 0.20 0.07 blup 38 0.07 1.5e-03 -3.4 5.7 1.5e-08 0.61 0.02 0.42 FALSE
51 The Cancer Genome Atlas Thyroid Carcinoma MARK3 0.10 0.03 blup 61 0.03 4.0e-04 6.5 6.2 4.6e-10 0.74 0.01 0.75 FALSE